Bristol Myers Squibb
The Executive Director leads immunology external innovation within Integrative Sciences, serving as a key interface across Global Research, Early Development, and Business Development to identify and advance high-value external scientific opportunities. This senior role involves evaluating academic collaborations, biotech partnerships, and pre-IND or IND-stage assets to strengthen the BMS pipeline. The position requires strategic leadership in collaboration design, governance, and cross-functional execution to drive decision-ready programs in immune-mediated diseases.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
Associate Director, Immunobiology Open Innovation
biogen
Director, Immunology Scientific Innovation
AstraZeneca
Director, Immunology Scientific Innovation
AstraZeneca
Senior Director, Immunometabolic Health and Immunology Research
Eli Lilly and Company
Senior Director, Immunology Early Development Strategy & Innovation
biogen
Associate Principal Scientist, Immunology Biomarker Lead, Translational Medicine
Merck & Co., Inc.